799 related articles for article (PubMed ID: 18702744)
1. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
[TBL] [Abstract][Full Text] [Related]
2. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
Sikora JP; Kuzański W; Andrzejewska E
Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
[TBL] [Abstract][Full Text] [Related]
4. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation.
Miyaoka K; Iwase M; Suzuki R; Kondo G; Watanabe H; Ito D; Nagumo M
J Surg Res; 2005 May; 125(2):144-50. PubMed ID: 15854666
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
9. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
10. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
11. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.
Locker GJ; Kofler J; Stoiser B; Wilfing A; Wenzel C; Wögerbauer M; Steger GG; Zielinski CC; Mader R; Burgmann H
Eur Cytokine Netw; 2000 Sep; 11(3):391-6. PubMed ID: 11022123
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome.
Vindenes HA; Ulvestad E; Bjerknes R
Eur J Surg; 1998 Sep; 164(9):647-56. PubMed ID: 9728783
[TBL] [Abstract][Full Text] [Related]
13. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options.
Gogos CA; Drosou E; Bassaris HP; Skoutelis A
J Infect Dis; 2000 Jan; 181(1):176-80. PubMed ID: 10608764
[TBL] [Abstract][Full Text] [Related]
14. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.
Mwatha JK; Kimani G; Kamau T; Mbugua GG; Ouma JH; Mumo J; Fulford AJ; Jones FM; Butterworth AE; Roberts MB; Dunne DW
J Immunol; 1998 Feb; 160(4):1992-9. PubMed ID: 9469463
[TBL] [Abstract][Full Text] [Related]
15. [Cytokines and soluble cytokine receptors in the perioperative period].
Maruna P; Gürlich R; Frasko R; Chachkhiani I; Marunová M; Owen K; Pesková M
Sb Lek; 2002; 103(2):273-82. PubMed ID: 12688152
[TBL] [Abstract][Full Text] [Related]
16. Cytokine expression profile over time in severely burned pediatric patients.
Finnerty CC; Herndon DN; Przkora R; Pereira CT; Oliveira HM; Queiroz DM; Rocha AM; Jeschke MG
Shock; 2006 Jul; 26(1):13-9. PubMed ID: 16783192
[TBL] [Abstract][Full Text] [Related]
17. The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery.
Krohn CD; Reikerås O; Aasen AO
Eur J Surg; 1999 Feb; 165(2):101-9. PubMed ID: 10192566
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency.
Takala A; Jousela I; Olkkola KT; Jansson SE; Leirisalo-Repo M; Takkunen O; Repo H
Clin Sci (Lond); 1999 Mar; 96(3):287-95. PubMed ID: 10029565
[TBL] [Abstract][Full Text] [Related]
20. Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?
Slotwinski R; Olszewski WL; Slotkowski M; Lech G; Zaleska M; Slotwinska SM; Krasnodebski WI
JOP; 2007 Nov; 8(6):759-69. PubMed ID: 17993728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
